When NOT to use peptides — the hard contraindications

Most peptide content focuses on what to take and how. This guide is about what should make you stop and not start. These aren't "be cautious" notes. These are situations where the realistic risk-reward goes negative for almost everyone, regardless of how good the peptide is for someone in a different situation.

Pregnancy and breastfeeding

Hard no across every category. Almost no peptide has been studied in pregnant or nursing humans. The fetal/infant risk is unknown for most compounds. The default assumption in this category is risk > benefit unless a doctor specifically prescribes something for a known condition.

This applies to GLP-1 weight-loss compounds (tirzepatide, semaglutide, retatrutide) where there is active concern about fetal effects, GH-axis peptides, healing peptides like BPC-157, and especially MT-2 (which crosses the placenta). If you're pregnant, trying to conceive in the next 90 days, or breastfeeding, this isn't the right category for you. Wait.

Active or recent cancer

Many peptides influence cell growth, signaling, or vascularization. Several (the GH-axis class, IGF-1-related peptides) increase IGF-1 levels — and IGF-1 is implicated in tumor proliferation in some cancer types. Healing peptides like BPC-157 and TB-500 promote angiogenesis (new blood vessel growth) which can theoretically support tumor growth.

If you're in active treatment for cancer, post-treatment surveillance, or have a personal/strong family history of certain cancers (especially hormone-sensitive cancers — breast, prostate, certain thyroid cancers), peptides aren't the right call without specific medical guidance. Talk to your oncologist before considering anything.

Recent surgery or major injury (timing matters)

This one is more nuanced because some peptides (BPC-157, TB-500) are explicitly studied for post-injury recovery. Where it goes wrong:

• Within 14 days of surgery: stop all peptides. Anesthesia, anticoagulant interactions, and immune response are all in flux. Adding signaling compounds is a bad time.
• On anticoagulants (warfarin, Eliquis, Xarelto): BPC-157 has anti-thrombotic activity in animal models. Risk of unpredictable bleeding interactions is real.
• Post-organ-transplant: hard no. Immune-modulating peptides could disrupt transplant tolerance.

The right window for healing peptides is usually 2-4 weeks post-op, after acute healing has stabilized, with your surgeon's awareness.

Certain medications

Some drug classes interact unpredictably with peptides:

Insulin and other diabetes drugs: GLP-1 peptides plus insulin = real hypoglycemia risk. If you're on insulin, sulfonylureas, or other glucose-lowering medication, GLP-1 dose adjustments need a doctor in the loop.

Anticoagulants: BPC-157, TB-500, omega-3 supplementation, and several other compounds have mild blood-thinning effects. Stacking with prescription anticoagulants raises bleeding risk.

Immunosuppressants: thymic peptides (Thymosin alpha-1, TB-500) modulate immune function. Combining with cyclosporine, tacrolimus, or other immunosuppressants can blunt or amplify the prescribed effect unpredictably.

Levothyroxine and thyroid medications: not a hard contraindication, but GH-axis peptides can shift thyroid demand. Re-test TSH after 8-12 weeks if on thyroid medication.

SSRIs and serotonergic drugs: PT-141 has serotonergic effects. Combining with high-dose SSRI/SNRI is the risk pattern; mild interactions are possible.

Active untreated mental health conditions

Peptides aren't psychiatric medications, but they can shift mood, sleep, and stress response in ways that compound existing instability. Active untreated depression, bipolar disorder, severe anxiety, or eating disorders make it harder to attribute changes to the peptide vs the underlying condition. Get the underlying condition managed first.

GLP-1s in particular have generated reports of mood changes (most users feel fine, some report low mood). If you have a history of suicidal ideation or active mood episodes, this isn't the time.

Severe kidney or liver disease

Most peptides are cleared via hepatic metabolism or renal excretion. If kidney function (eGFR) is below 60 or you have known liver disease, drug-handling is impaired and routine doses behave unpredictably. This is doctor territory.

Under 18

Pepdex content is for adults. Not because the molecules are dangerous in absolute terms but because growing adolescents are in active hormonal development. Adding exogenous signaling at that stage is genuinely a different risk picture.

You're using to compete in tested sport

This isn't a contraindication for safety — it's a contraindication for your career. Many peptides are on the WADA prohibited list. If you compete in any tested sport (NCAA, Olympic, military, professional leagues with drug testing), assume any peptide is a risk to your eligibility. Check the current WADA list before starting anything. See Peptide status explained.

You don't have a real "why"

This isn't a safety contraindication, it's a quality-of-decision check. If you can't articulate what specific outcome you're aiming for and how you'll know it's working, you're going to spend money, take a risk, and learn nothing useful. Wait until you have a real protocol question.

What to do if any of the above applies

1. Don't start. Or stop if you've started. 2. Talk to your doctor. Bring the list of compounds you were considering. They may not endorse, but they should advise. 3. Wait until conditions change. Pregnancy ends. Cancer treatment finishes. Surgery heals. Mental health stabilizes. 4. The compound will still be there in 6 months. Most peptide outcomes accrue slowly anyway. Acting from a worse setup just makes results harder to interpret.

Pepdex covers a lot of compounds, but the right answer for any individual is sometimes "not now, not for you." Knowing that is harm reduction, not gatekeeping.